We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cell Makeup Affects Immunity in the Elderly

By Biotechdaily staff writers
Posted on 29 May 2002
New evidence helps to explain why the immune system of elderly people is less capable of fighting off infections. More...
In a study of transgenic mice, researchers from National Jewish Medical and Research Center (Denver CO, USA) found that as the body ages it becomes increasingly dependent on less effective antigen-experienced B cells. These do not counter infection as well as naive B cells, which predominate in younger individuals. The findings appear in the May 15, 2002, issue of The Journal of Immunology.

Researchers had been puzzled by the fact that although production of new B cells declines with age, the number of circulating B cells remains nearly constant. Dr. John Cambier and his colleagues hypothesized that older mice maintain high B-cell levels by stockpiling antigen-experienced B cells. Exposure to foreign pathogens helps them live longer than naive B cells, which usually die after five to six weeks if they do not encounter a pathogen.

Antibodies secreted by antigen-experienced B cells are made to fight a previous pathogen and generally do not bind strongly to the current one. Naive B cells can mount a more potent defense because they custom-tailor their antibodies to the current pathogen, allowing the antibodies to bind strongly.

The investigators examined the B cells in mice less than three months of age and mice older than 22 months. They used a number of cell characteristics, including cell-surface receptors and antibody expression, to distinguish antigen-experienced B cells from naive ones. One kind of naive B cell, called a follicular cell, decreased from an average of 70% of the B-cell population in young mice to 32% in older mice. In another analysis, results indicated that only about 5% of the B cells in young mice were antigen-experienced, but they accounted for 76% of the B cells in older mice. "These numbers are averages,” said co-author Sarah Johnson. "The B cell populations of individual mice varied, with some retaining large numbers of naive B cells and other carrying almost none. The mice with many naive B cells would presumably be better at fighting off infections.”

In a later study, hematopoietic stem cells from young mice were transplanted into old mice. Initial results suggest that the transplantation restores the B cell population to a younger, more naive and adaptable profile.




Related Links:
National Jewish Medical and Research Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Silver Member
Connectivity Solution
EKF Link
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.